Article Information
History
- June 28, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bouchra. Rezzouk1,*,
- Tarik. Bouattar2,3,
- Bouchra. Belkadi1,
- Rachid. Razine3,
- Rabia. Bayahia2,3,
- Naima. Ouzeddoun2,3,
- Loubna. Benamar2,3,
- Hakima. Rhou4,
- Najat. Bouihat5,
- Azeddine Ibrahimi3,6,
- Myriam. Seffar3,5 and
- Hakima. Kabbaj3,5
- 1Laboratory of Microbiology and Molecular Biology, Faculty of Science, University Mohammed V, Rabat, Morocco
- 2Department of Nephrology-Dialysis-Renal transplantation, Ibn Sina University Hospital Center, Rabat, Morocco
- 3Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 4Department of Nephrology – Dialysis-Renal transplantation, Sheikh Zaid International University Hospital, Rabat, Morocco
- 5Central Laboratory of Virology, Hospital of Specialties, Ibn Sina University Hospital Center, Rabat, Morocco
- 6Biotech Laboratory (Med Biotech), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- ↵*Corresponding author E-mail: boraressa12{at}yahoo.fr (BR)
Posted June 28, 2019.
Current characteristics and outcomes of Cytomegalovirus Reactivation in kidney transplant seropositive recipients in the era of prophylaxis treatment. Lesson from single Moroccan center experience
